And while epilepsy was the main treatment purpose for Neurontin originally there is other information about it which I hadn't heard about before:
Huge penalty in drug fraudPfizer settles felony case in Neurontin off-label promotion
Bernadette Tansey, Chronicle Staff Writer
Friday, May 14, 2004
(a portion of the article)
"Doctors are free to prescribe drugs for uses not specified on their FDA- approved labels, but the FDA forbids drug companies from promoting them for those off-label uses. Prosecutors said Neurontin's manufacturers decided not to seek an expanded FDA label for the drug, an expensive process requiring solid proof from clinical trials. Instead, the company boosted sales through aggressive promotional strategies, even when scientific studies had demonstrated that it was not effective, the Justice Department said.
The tactics included planting company operatives in the audience at medical education events to contradict unfavorable comments about Neurontin, and paying doctors to allow sales representatives to sit in on patient visits, prosecutors said.
Such methods were first revealed by the whistle-blower, David Franklin, a former medical liaison for Warner-Lambert who filed suit on behalf of the government. By some estimates, as much as 90 percent of Neurontin prescriptions were for off-label uses during the marketing campaign that prosecutors said dates back to about 1995. Neurontin's sales soared from $97.5 million in 1995 to nearly $2.7 billion in 2003."
It has been found to be useful in treating many other conditions it was never intended for, including nerve pain.